Smoked cannabis as an adjunctive second-line therapy to treat chronic peripheral neuropathy can be both effective and cost-effective, suggests a new study that used a computer simulation model to simulate its use in one million patients. submitted by /u/mvea
[link] [comments]


from Health http://bit.ly/2HE9Y9p
Share To:

Unknown

Post A Comment:

0 comments so far,add yours